Optimising treatment of schizophrenia: the role of adjunctive fluvoxamine

Psychopharmacology (Berl). 2016 Mar;233(5):739-40. doi: 10.1007/s00213-016-4207-z. Epub 2016 Jan 16.

Authors

Siobhan Gee¹, Oliver Howes²

Affiliations

¹ South London and Maudsley NHS Foundation Trust, Pharmacy Department, Bethlem Royal Hospital, Monks Orchard Road, Beckenham, BR3 3BX, UK. Siobhan.Gee@slam.nhs.uk.
² Institute of Psychiatry, King's College London, Camberwell, SE5 8AF, London, UK.

PMID: 26780617
DOI: 10.1007/s00213-016-4207-z

No abstract available

Publication types

Editorial

Grants and funding